Altered Fibrin Network Structure and Fibrinolysis in Intensive Care Unit Patients with COVID-19, Not Entirely Explaining the Increased Risk of Thrombosis
Overview
Authors
Affiliations
Background: Severe acute respiratory syndrome coronavirus 2 infection is associated with an increased incidence of thrombosis.
Objectives: By studying the fibrin network structure of coronavirus disease 2019 (COVID-19) patients, we aimed to unravel pathophysiological mechanisms that contribute to this increased risk of thrombosis. This may contribute to optimal prevention and treatment of COVID-19 related thrombosis.
Patients/methods: In this case-control study, we collected plasma samples from intensive care unit (ICU) patients with COVID-19, with and without confirmed thrombosis, between April and December 2020. Additionally, we collected plasma from COVID-19 patients admitted to general wards without thrombosis, from ICU patients with pneumococcal infection, and from healthy controls. Fibrin fiber diameters and fibrin network density were quantified in plasma clots imaged with stimulated emission depletion microscopy and confocal microscopy. Finally, we determined the sensitivity to fibrinolysis.
Results: COVID-19 ICU patients (n = 37) and ICU patients with pneumococcal disease (n = 7) showed significantly higher fibrin densities and longer plasma clot lysis times than healthy controls (n = 7). No differences were observed between COVID-19 ICU patients with and without thrombosis, or ICU patients with pneumococcal infection. At a second time point, after diagnosis of thrombosis or at a similar time point in patients without thrombosis, we observed thicker fibers and longer lysis times in COVID-19 ICU patients with thrombosis (n = 19) than in COVID-19 ICU patients without thrombosis (n = 18).
Conclusions: Our results suggest that severe COVID-19 is associated with a changed fibrin network structure and decreased susceptibility to fibrinolysis. Because these changes were not exclusive to COVID-19 patients, they may not explain the increased thrombosis risk.
Clot formation, structure, and fibrinolysis of pancreatic cancer patients.
Risman R, Milman N, Sinan H, Tutwiler V Res Sq. 2025; .
PMID: 39989974 PMC: 11844638. DOI: 10.21203/rs.3.rs-5868575/v1.
Deconstructing fibrin(ogen) structure.
Risman R, Sen M, Tutwiler V, Hudson N J Thromb Haemost. 2024; 23(2):368-380.
PMID: 39536819 PMC: 11786978. DOI: 10.1016/j.jtha.2024.10.024.
Risman R, Belcher H, Ramanujam R, Weisel J, Hudson N, Tutwiler V Biomolecules. 2024; 14(2).
PMID: 38397467 PMC: 10886591. DOI: 10.3390/biom14020230.
Flow affects the structural and mechanical properties of the fibrin network in plasma clots.
Eyisoylu H, Hazekamp E, Cruts J, Koenderink G, de Maat M J Mater Sci Mater Med. 2024; 35(1):8.
PMID: 38285167 PMC: 10824866. DOI: 10.1007/s10856-024-06775-1.
What is the diameter of a fibrin fiber?.
Belcher H, Guthold M, Hudson N Res Pract Thromb Haemost. 2023; 7(5):100285.
PMID: 37601015 PMC: 10439396. DOI: 10.1016/j.rpth.2023.100285.